Questionnaire and diary are encrypted with your password and stored only in this browser. The site owner does not receive them.
Weight Loss Trajectory Tracker
Log daily or weekly weigh-ins to monitor fat loss rate during triple agonist Retatrutide (GIP/GLP-1/GCG) therapy.
Weight Loss Dynamics & Weekly Progress
Recharts visualization: absolute weight, weekly fat loss rate, and dosage titration
Add New Weigh-in Record
- Morning Standard: Weigh on an empty stomach, after using the restroom, at the same time each day.
- Fluctuation Norms: Daily weight may fluctuate ±1.5 kg due to fluid retention, salt, or hydration. Evaluate smoothed trend line!
- Retatrutide Efficacy: In TRIUMPH-1 trial, mean weight loss reached -28.3% at 80 weeks (and -30.3% at 104 weeks in the extension) on 12 mg dose.
History Log (15)
No record limit; sorted oldest to newest| Date | Weight (kg) | BMI | Change | Retatrutide Dose | Waist (cm) | Notes | Actions |
|---|---|---|---|---|---|---|---|
| Apr 01, 2026 | 102.5 kg | 33.5 | Starttotal: +0 kg | 2 mg | 108 cm | Started Retatrutide titration 2 mg | |
| Apr 08, 2026 | 101.2 kg | 33 | -1.3 kgtotal: -1.3 kg | 2 mg | 107 cm | Reduced appetite from Day 2 | |
| Apr 15, 2026 | 100.1 kg | 32.7 | -1.1 kgtotal: -2.4 kg | 2 mg | 106 cm | Early satiety | |
| Apr 22, 2026 | 99.3 kg | 32.4 | -0.8 kgtotal: -3.2 kg | 2 mg | 105 cm | Lost 3.2 kg in first 3 weeks | |
| Apr 29, 2026 | 98.4 kg | 32.1 | -0.9 kgtotal: -4.1 kg | 4 mg | 104 cm | Increased dose to 4 mg | |
| May 06, 2026 | 97.2 kg | 31.7 | -1.2 kgtotal: -5.3 kg | 4 mg | 103 cm | Mild nausea on day 1 post injection | |
| May 13, 2026 | 96.1 kg | 31.4 | -1.1 kgtotal: -6.4 kg | 4 mg | 102 cm | Feeling great, energy expenditure up | |
| May 20, 2026 | 95 kg | 31 | -1.1 kgtotal: -7.5 kg | 4 mg | 101 cm | Lost 7.5 kg from baseline | |
| May 27, 2026 | 94.2 kg | 30.8 | -0.8 kgtotal: -8.3 kg | 4 mg | 100 cm | Steady weight loss | |
| Jun 03, 2026 | 93.1 kg | 30.4 | -1.1 kgtotal: -9.4 kg | 8 mg | 99 cm | Escalated to 8 mg maintenance dose | |
| Jun 10, 2026 | 91.8 kg | 30 | -1.3 kgtotal: -10.7 kg | 8 mg | 98 cm | Enhanced fat oxidation (triple agonism) | |
| Jun 17, 2026 | 90.7 kg | 29.6 | -1.1 kgtotal: -11.8 kg | 8 mg | 97 cm | Waist circumference reduced by 11 cm | |
| Jun 24, 2026 | 89.6 kg | 29.3 | -1.1 kgtotal: -12.9 kg | 8 mg | 96 cm | Continuing therapy | |
| Jul 01, 2026 | 88.8 kg | 29 | -0.8 kgtotal: -13.7 kg | 8 mg | 95 cm | Maintaining strong trajectory | |
| Jul 08, 2026 | 88 kg | 28.7 | -0.8 kgtotal: -14.5 kg | 8 mg | 94 cm | Current total: -14.5 kg (-14.1%) |
Weight & Health Metrics: glucose, uric acid, cholesterol, blood pressure
One table, no record limit. Weight entered here also goes to the weight diary. After login the data is stored on the server and deleted together with the profile.
- Glucose
- Weight, kg (right axis)
- Uric acid
- Weight, kg (right axis)
- LDL
- Total cholesterol
- Weight, kg (right axis)
- Diastolic BP
- Systolic BP
- Weight, kg (right axis)
| Date | Weight | Glucose | Uric acid | Total cholesterol | LDL | Systolic BP | Diastolic BP | Notes | |
|---|---|---|---|---|---|---|---|---|---|
| Jul 08, 26 | 88 | — | — | — | — | — | — | — | |
| Jul 01, 26 | 88.8 | — | — | — | — | — | — | — | |
| Jun 24, 26 | 89.6 | — | — | — | — | — | — | — | |
| Jun 17, 26 | 90.7 | — | — | — | — | — | — | — | |
| Jun 10, 26 | 91.8 | — | — | — | — | — | — | — | |
| Jun 03, 26 | 93.1 | — | — | — | — | — | — | — | |
| May 27, 26 | 94.2 | — | — | — | — | — | — | — | |
| May 20, 26 | 95 | — | — | — | — | — | — | — | |
| May 13, 26 | 96.1 | — | — | — | — | — | — | — | |
| May 06, 26 | 97.2 | — | — | — | — | — | — | — | |
| Apr 29, 26 | 98.4 | — | — | — | — | — | — | — | |
| Apr 22, 26 | 99.3 | — | — | — | — | — | — | — | |
| Apr 15, 26 | 100.1 | — | — | — | — | — | — | — | |
| Apr 08, 26 | 101.2 | — | — | — | — | — | — | — | |
| Apr 01, 26 | 102.5 | — | — | — | — | — | — | — |
Dashed lines are common reference limits for adults (fasting glucose 5.5, uric acid 360 F / 420 M, total cholesterol 5.2, LDL 3.0, BP 130/80). For information only; targets are set by your doctor.